Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairs

JP. Dijksterhuis, B. Baljinnyam, K. Stanger, HO. Sercan, Y. Ji, O. Andres, JS. Rubin, RN. Hannoush, G. Schulte,

. 2015 ; 290 (11) : 6789-98.

Language English Country United States

Document type Journal Article, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't

The seven-transmembrane-spanning receptors of the FZD1-10 class are bound and activated by the WNT family of lipoglycoproteins, thereby inducing a complex network of signaling pathways. However, the specificity of the interaction between mammalian WNT and FZD proteins and the subsequent signaling cascade downstream of the different WNT-FZD pairs have not been systematically addressed to date. In this study, we determined the binding affinities of various WNTs for different members of the FZD family by using bio-layer interferometry and characterized their functional selectivity in a cell system. Using purified WNTs, we show that different FZD cysteine-rich domains prefer to bind to distinct WNTs with fast on-rates and slow off-rates. In a 32D cell-based system engineered to overexpress FZD2, FZD4, or FZD5, we found that WNT-3A (but not WNT-4, -5A, or -9B) activated the WNT-β-catenin pathway through FZD2/4/5 as measured by phosphorylation of LRP6 and β-catenin stabilization. Surprisingly, different WNT-FZD pairs showed differential effects on phosphorylation of DVL2 and DVL3, revealing a previously unappreciated DVL isoform selectivity by different WNT-FZD pairs in 32D cells. In summary, we present extensive mapping of WNT-FZD cysteine-rich domain interactions complemented by analysis of WNT-FZD pair functionality in a unique cell system expressing individual FZD isoforms. Differential WNT-FZD binding and selective functional readouts suggest that endogenous WNT ligands evolved with an intrinsic natural bias toward different downstream signaling pathways, a phenomenon that could be of great importance in the design of FZD-targeting drugs.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15022856
003      
CZ-PrNML
005      
20150723112702.0
007      
ta
008      
150709s2015 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1074/jbc.M114.612648 $2 doi
035    __
$a (PubMed)25605717
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Dijksterhuis, Jacomijn P $u From the Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockholm, Sweden, the Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892.
245    10
$a Systematic mapping of WNT-FZD protein interactions reveals functional selectivity by distinct WNT-FZD pairs / $c JP. Dijksterhuis, B. Baljinnyam, K. Stanger, HO. Sercan, Y. Ji, O. Andres, JS. Rubin, RN. Hannoush, G. Schulte,
520    9_
$a The seven-transmembrane-spanning receptors of the FZD1-10 class are bound and activated by the WNT family of lipoglycoproteins, thereby inducing a complex network of signaling pathways. However, the specificity of the interaction between mammalian WNT and FZD proteins and the subsequent signaling cascade downstream of the different WNT-FZD pairs have not been systematically addressed to date. In this study, we determined the binding affinities of various WNTs for different members of the FZD family by using bio-layer interferometry and characterized their functional selectivity in a cell system. Using purified WNTs, we show that different FZD cysteine-rich domains prefer to bind to distinct WNTs with fast on-rates and slow off-rates. In a 32D cell-based system engineered to overexpress FZD2, FZD4, or FZD5, we found that WNT-3A (but not WNT-4, -5A, or -9B) activated the WNT-β-catenin pathway through FZD2/4/5 as measured by phosphorylation of LRP6 and β-catenin stabilization. Surprisingly, different WNT-FZD pairs showed differential effects on phosphorylation of DVL2 and DVL3, revealing a previously unappreciated DVL isoform selectivity by different WNT-FZD pairs in 32D cells. In summary, we present extensive mapping of WNT-FZD cysteine-rich domain interactions complemented by analysis of WNT-FZD pair functionality in a unique cell system expressing individual FZD isoforms. Differential WNT-FZD binding and selective functional readouts suggest that endogenous WNT ligands evolved with an intrinsic natural bias toward different downstream signaling pathways, a phenomenon that could be of great importance in the design of FZD-targeting drugs.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčné linie $7 D002460
650    _2
$a frizzled receptory $x metabolismus $7 D051157
650    _2
$a myši $7 D051379
650    _2
$a fosforylace $7 D010766
650    _2
$a mapování interakce mezi proteiny $7 D025941
650    12
$a mapy interakcí proteinů $7 D060066
650    _2
$a protein - isoformy $x metabolismus $7 D020033
650    _2
$a proteiny Wnt $x metabolismus $7 D051153
650    12
$a signální dráha Wnt $7 D060449
650    _2
$a beta-katenin $x metabolismus $7 D051176
655    _2
$a časopisecké články $7 D016428
655    _2
$a Research Support, N.I.H., Intramural $7 D052060
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Baljinnyam, Bolormaa $u the Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892.
700    1_
$a Stanger, Karen $u the Department of Early Discovery Biochemistry, Genentech, South San Francisco, California 94080, and.
700    1_
$a Sercan, Hakki O $u the Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892.
700    1_
$a Ji, Yun $u the Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892.
700    1_
$a Andres, Osler $u the Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892. $7 gn_A_00006542
700    1_
$a Rubin, Jeffrey S $u the Laboratory of Cellular and Molecular Biology, Center for Cancer Research, NCI, National Institutes of Health, Bethesda, Maryland 20892.
700    1_
$a Hannoush, Rami N $u the Department of Early Discovery Biochemistry, Genentech, South San Francisco, California 94080, and hannoush.rami@gene.com.
700    1_
$a Schulte, Gunnar $u From the Section of Receptor Biology and Signaling, Department of Physiology and Pharmacology, Karolinska Institutet, S-171 77 Stockholm, Sweden, the Faculty of Science, Institute of Experimental Biology, Masaryk University, 611 37 Brno, Czech Republic gunnar.schulte@ki.se.
773    0_
$w MED00002546 $t The Journal of biological chemistry $x 1083-351X $g Roč. 290, č. 11 (2015), s. 6789-98
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25605717 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150723112740 $b ABA008
999    __
$a ok $b bmc $g 1083195 $s 905849
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 290 $c 11 $d 6789-98 $i 1083-351X $m The Journal of biological chemistry $n J Biol Chem $x MED00002546
LZP    __
$a Pubmed-20150709

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...